2004Yanwaishang zhiye yanbing zazhiRequires access

Treating hyperopia with laser in situ keratomileusis

LI Li, Z. TAO, 高如尧, 卢佩勇, 蒙艳春

Open publisher page 0 citations

Abstract

目的 评价准分子激光原位角膜磨镶术(LASIK)治疗的效果和安全性.方法对16例(30眼)远视行LASIK.术前远视度数为+3.50~+12.5D,平均(+7.09±2.62)D.术后随访观察12月.结果术中无严重并发症,术后3月屈光度基本稳定,术后12月残余屈光度在+1.00D和+2.00D以内的分别占40.00%(12眼)和63.33%(19眼),裸眼近视力≥0.5者30眼(100.00%),≥1.0者24眼(80.00%),裸眼远视力≥0.5者26眼(86.67%),≥1.0者9眼(30.00%),1眼(3.33%)最佳矫正视力下降一行,5眼(16.67%)有眩光.结论 LASIK治疗远视安全有效.治疗软件进一步完善及治疗参数进一步的调整将有助于提高手术的可预测性和稳定性。

About this research paper

What this paper is about

目的 评价准分子激光原位角膜磨镶术(LASIK)治疗的效果和安全性.方法对16例(30眼)远视行LASIK.术前远视度数为+3.50~+12.5D,平均(+7.09±2.62)D.术后随访观察12月.结果术中无严重并发症,术后3月屈光度基本稳定,术后12月残余屈光度在+1.00D和+2.00D以内的分别占40.00%(12眼)和63.33%(19眼),裸眼近视力≥0.5者30眼(100.00%),≥1.0者24眼(80.00%),裸眼远视力≥0.5者26眼(86.67%),≥1.0者9眼(30.00%),1眼(3.33%)最佳矫正视力下降一行,5眼(16.67%)有眩光.结论 LASIK治疗远视安全有效.治疗软件进一步完善及治疗参数进一步的调整将有助于提高手术的可预测性和稳定性。

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

目的 评价准分子激光原位角膜磨镶术(LASIK)治疗的效果和安全性.方法对16例(30眼)远视行LASIK.术前远视度数为+3.50~+12.5D,平均(+7.09±2.62)D.术后随访观察12月.结果术中无严重并发症,术后3月屈光度基本稳定,术后12月残余屈光度在+1.00D和+2.00D以内的分别占40.00%(12眼)和63.33%(19眼),裸眼近视力≥0.5者30眼(100.00%),≥1.0者24眼(80.00%),裸眼远视力≥0.5者26眼(86.67%),≥1.0者9眼(30.00%),1眼(3.33%)最佳矫正视力下降一行,5眼(16.67%)有眩光.结论 LASIK治疗远视安全有效.治疗软件进一步完善及治疗参数进一步的调整将有助于提高手术的可预测性和稳定性。

Key concepts: Keratomileusis, Medicine, Ophthalmology, In situ, Chemistry, Cornea, Organic chemistry

Related papers

Back to paper searchBrowse research topicsOriginal source
Treating hyperopia with laser in situ keratomileusis — Research Paper | ScholarLens